Most Israeli tech companies start with a Dutch or Luxembourg sales company owned by the Israeli parent, and add a holding when acquisitions or European investors arrive. Both countries pay dividends to the Israeli parent at 0%. What decides the structure is Israeli: a board deciding from Tel Aviv makes the EU company Israeli-resident, IP usually stays in Israel under its own regime, and a flip needs a ruling.
Why Israeli tech companies build in Europe
For an Israeli software, cyber or medtech company Europe is usually the second market after the US, and it asks for a local face: a contracting entity customers can sign with, an employer for the sales team, a VAT number, a GDPR representative, sometimes an EU company to bid for grants or public contracts. As the business grows, European acquisitions and European investors follow, and with them the question of a holding.
Luxembourg and the Netherlands are the natural bases. Both have treaties with Israel, both pay dividends to an Israeli parent without withholding tax when the conditions are met, and both offer IP regimes. But the Israeli rules on residence, IP transfers and funded know-how shape the structure more than anything in Europe.
The first step
A Dutch B.V. or Luxembourg S.à r.l. that sells, invoices and employs, owned by the Israeli company.
When acquisitions come
One company above the European subsidiaries, to finance, own and sell them.
When EU money comes in
A Luxembourg SCSp or S.à r.l. for European funds and co-investors.
Handle with care
Israeli exit taxes and Innovation Authority rules make moving IP expensive.
The Israeli rules that shape the structure
- Management and control. A foreign company managed and controlled from Israel is Israeli-resident and pays 23% on its worldwide income. A board of Tel Aviv founders deciding on Zoom is the classic trap.
- No participation exemption at home. Dividends from Europe to an Israeli company are taxed at 23%, with a credit for foreign tax, and an optional credit for the underlying corporate tax. Profits often stay in Europe until needed.
- CFC rules for passive companies. A foreign company controlled from Israel, earning mainly passive income taxed at 15% or less, is taxed in the hands of its 10%+ Israeli shareholders as a deemed dividend. A normally taxed EU holding clears the 15% test; an IP-box company may not.
- Moving IP is a sale. Israeli courts treat post-acquisition restructurings as a deemed sale of IP and functions, as in the Medtronic case. Know-how funded by the Innovation Authority needs its approval and a redemption payment of up to six times the grants.
The European half is the easy half. What decides an Israeli structure is where the board sits and where the IP stays.
Dividends, interest and royalties between Israel and Europe
| Payment | Israel–Luxembourg | Israel–Netherlands |
|---|---|---|
| Dividends from Israel to the EU company | 5% at 10%+; 10% on profits taxed at reduced rates; 15% otherwise | 5% / 10% / 15% depending on the holding |
| Dividends from Israel on technology-enterprise profits | 4% if 90%+ foreign-owned (Israeli law) | 4% if 90%+ foreign-owned (Israeli law) |
| Dividends from the EU company to an Israeli parent | 0% under Luxembourg's domestic exemption at 10% / 12 months | 0% under the Dutch exemption for treaty residents |
| Interest from Israel | 10% (5% banks) | 15% (10% banks) |
| Royalties from Israel | 5% | 5% (10% film) |
| Anti-abuse | Principal purpose test through the MLI | Principal purpose test through the MLI |
Israel's domestic rates without a treaty are 25% or 30% on dividends and 23% on interest and royalties. Israel is not on the Dutch list of low-tax jurisdictions.
Plan your route
Five questions, one view of the structure.
Plan your Israeli route into Europe
Five questions. You see the structure, the Israeli rules that bite and what to do first.
Keep the IP in Israel, license it to Europe
| Regime | Rate | Catch |
|---|---|---|
| Israel, technological enterprise | 12% (7.5% in development area A; 6% for very large groups) | Needs Israeli R&D; 4% dividend withholding to foreign parents |
| Luxembourg IP regime | About 5.2% | Nexus: only income from R&D done by the company itself |
| Dutch innovation box | 9% | Nexus and an R&D declaration (WBSO) |
Because the European IP regimes only reward R&D done in Europe, IP developed in Israel gains little from moving, and the move itself can trigger Israeli tax and Innovation Authority payments. The usual answer is to keep the IP in Israel and give the European company a licence or a distribution role, priced at arm's length.
Founders, flips and European investors
Founders who hold a European company personally pay Israeli tax on its dividends at 25%, or 30% with a 10% stake, plus a surtax of up to 5% on high capital income. A passive European holding owned by Israeli founders can also fall under the CFC rules. Most founders are better off holding through their Israeli company.
When European investors or an exit call for a European parent above the Israeli company, the flip is a taxable event in Israel unless structured under a ruling, and Israeli dividends to the new parent carry treaty withholding. Plan the flip with your Israeli counsel before signing the term sheet.
Management from Israel makes the EU company Israeli-resident.
Israeli regimes, deemed-sale cases and IIA fees favour licensing.
Both countries pay an Israeli parent without withholding tax.
Putting an EU parent on top is a taxable event in Israel.